269 results
P
monolithic translucent Y-TZP ceramics
I/C
hydrothermal aging, aged Y-TZP ceramics
O
translucency parameter (TP), L*
P
Laparoscopic Roux-en-Y gastric bypass, laparoscopic sleeve gastrectomy
I/C
Laparoscopic Roux-en-Y gastric bypass, laparoscopic sleeve gastrectomy, Laparoscopic Roux-en-Y gastric bypass vs. laparoscopic sleeve gastrectomy
O
Excess weight loss, Type 2 diabetes mellitus resolution, Postoperative complication and reoperation rates, Dyslipidemia, Hypertension, Gastroesophageal reflux disease
P
patients with allergic rhinitis
I/C
oral H, placebo
O
total symptom score reduction, nasal congestion score reduction, rhinorrhea score reduction, ocular symptom score reduction, nasal itching score reduction, sneezing score reduction
P
541 participants
I/C
periodontal treatment, conventional systemic H. pylori eradication therapy alone
O
gastric H. pylori eradication rates
P
animals
I/C
hypothermic machine perfusion, subnormothermic machine perfusion, warm ischemia without cold storage, normothermic machine perfusion, static cold storage (< 12 h), warm ischemia without cold storage, normothermic machine perfusion, static cold storage (< 12 h), static cold storage (≥ 12 h)
O
ATP content, respiratory activity of mitochondrial complexes, cytochrome c release, aspartate aminotransferase (ALT) release
P
working-age (≥15 years) workers in the formal and informal economy
I/C
exposure to long working hours (41-48, 49-54 and ≥55 h/week), exposure to standard working hours (35-40 h/week)
O
depression (prevalence, incidence and mortality)
P
Hu ML, Zheng G, Lin H, Yang M, Zhang YD, Han JM
I/C
Desensitizing Toothpastes
O
Dentine Hypersensitivity
P
Helicobacter pylori (H. pylori) positive peptic ulcer disease (PUD)
I/C
Chinese herbal formulae, conventional triple therapy (CON)
O
eradication rate, clinical efficiency, recurrence rate
P
FTSF, V-Y closure, perforator flap, non-perforator flap
I/C
separately combined full-thickness skin graft (FTSG), FTSG method based on V-Y closure, perforator flap, non-perforator flap
O
adapted FRFF size, postoperative complications
P
adult individuals
I/C
low-sodium salt substitute (LSSS), no LSSS
O
lower 24-h urinary sodium excretion